Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146547 | SCV000193843 | pathogenic | Cornelia de Lange syndrome 1 | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000082485 | SCV000225096 | pathogenic | not provided | 2012-08-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000082485 | SCV000565326 | pathogenic | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23760082, 16236812, 30158690, 36041635, 31337854, 31157197, 15318302, 20358602) |
Baylor Genetics | RCV000146547 | SCV000747066 | pathogenic | Cornelia de Lange syndrome 1 | 2022-12-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000146547 | SCV000934470 | pathogenic | Cornelia de Lange syndrome 1 | 2023-10-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg827Glyfs*2) in the NIPBL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NIPBL are known to be pathogenic (PMID: 15318302, 19763162, 23505322, 29995837). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Cornelia de Lange syndrome (PMID: 15318302, 17661813, 20358602, 20824775). ClinVar contains an entry for this variant (Variation ID: 96336). For these reasons, this variant has been classified as Pathogenic. |
Rady Children's Institute for Genomic Medicine, |
RCV000146547 | SCV001984850 | pathogenic | Cornelia de Lange syndrome 1 | 2020-06-02 | criteria provided, single submitter | clinical testing | This frameshifting variant in exon 10 of 47 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a heterozygous change in multiple unrelated individuals with Cornelia de Lange Syndrome (CdLS, PMID: 15318302, 17661813, 20358602, 20824775, 30158690, 31157197). Cells lines from a CdLS patient carrying this variant exhibited chromatin decompaction (PMID: 23760082). In addition, gene expression studies on human induced pluripotent stem cells and cardiomyocytes derived in-vitro from a carrier of this variant identified altered expression of genes involved in multiple cellular processes and normal heart development (PMID: 29348408). It is absent from the gnomAD population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.2479_2480del (p.Arg827GlyfsTer2) variant is classified as Pathogenic. |
Foundation for Research in Genetics and Endocrinology, |
RCV000146547 | SCV001985071 | pathogenic | Cornelia de Lange syndrome 1 | 2018-03-20 | criteria provided, single submitter | clinical testing | A heterozygous frameshift variation in exon 10 of the NIPBL gene that results in the termination of amino acid 2 codons downstream of Glycine at codon 827 was detected. The observed variant c.2479_2480delAG (p.Arg827GlyfsTer2) has not been reported in the 1000 gemomes, ExAC database. The in-silico prediction of the variant is disease causing by MutationTaster2. The reference codon is conserved across species. The segregation analysis showed this variation to be de novo in origin. In summary, the variant meets our criteria to be classified as a pathogenic variant. |
Genome- |
RCV000146547 | SCV002055964 | pathogenic | Cornelia de Lange syndrome 1 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000146547 | SCV000022385 | pathogenic | Cornelia de Lange syndrome 1 | 2004-10-01 | no assertion criteria provided | literature only | |
Division of Human Genetics, |
RCV000146547 | SCV002552099 | pathogenic | Cornelia de Lange syndrome 1 | no assertion criteria provided | research |